pharmaceutical companies manufacturing glp-1 receptor agonist medications How the market could hit $168bn by 2033 GLP-1 Receptor Agonist Market Valued

Medsafe says it has seen a sustained increase in illegal peptides at the border and complaints about online sales of these products

Acknowledgments This study was supported by the Cooperative Research Program for Agriculture Science & Technology Development (Project No

Supports nervous system function

Alam and Czajkowsky, 2022)

Einstein Foundation Berlin

In recent works, the study demonstrated that GCH1/ BH4 pathic enzyme dihydrofolate reductase (DHFR) could inhibit ferroptosis by generating BH4, so decrease in DHFR activity reduces BH4 content to enhance lipid peroxidation and sensitizes cells to ferroptosis (Lu et al., 2024), but the detail process is still unknown (Figure 1)